Characteristics, outcomes, and predictors of mortality at 3 months and 1 year in patients hospitalized for acute heart failure - PubMed (original) (raw)
Comparative Study
doi: 10.1093/eurjhf/hfq002.
Affiliations
- PMID: 20156940
- DOI: 10.1093/eurjhf/hfq002
Free article
Comparative Study
Characteristics, outcomes, and predictors of mortality at 3 months and 1 year in patients hospitalized for acute heart failure
Veli-Pekka Harjola et al. Eur J Heart Fail. 2010 Mar.
Free article
Abstract
Aims: Acute heart failure (AHF) has a poor prognosis. We evaluated 3- and 12-month mortality in different clinical classes of AHF patients from 30 European countries who were included in the EuroHeart Failure Survey (EHFS) II.
Methods and results: Follow-up data were available for 2981 AHF patients, of these 62% had a history of chronic HF. One-year mortality after discharge was lower in patients with de novo AHF when compared with acutely decompensated chronic HF (ADCHF), 16.4 vs. 23.2% (P < 0.001). Cardiogenic shock conferred the highest cumulative 1-year mortality (52.9%) as a result of in-hospital mortality of 39.3%. Long-term prognosis in decompensated AHF was also dismal. Hypertensive HF was associated with the lowest mortality (13.7% at 1 year). Age, prior myocardial infarction, creatinine level, and low plasma sodium were independently associated with mortality during the whole follow-up period. Diabetes, anaemia, and history of chronic HF were associated with worse and hypertension with better long-term survival. History of cerebrovascular disease was associated with worse short-term outcome.
Conclusion: Early and late mortality differ between de novo AHF and ADCHF and between clinical classes of AHF. EHFS II identifies clinical risk markers and demonstrates the importance of a thorough characterization of AHF populations according to history and clinical presentation.
Similar articles
- EuroHeart Failure Survey II (EHFS II): a survey on hospitalized acute heart failure patients: description of population.
Nieminen MS, Brutsaert D, Dickstein K, Drexler H, Follath F, Harjola VP, Hochadel M, Komajda M, Lassus J, Lopez-Sendon JL, Ponikowski P, Tavazzi L; EuroHeart Survey Investigators; Heart Failure Association, European Society of Cardiology. Nieminen MS, et al. Eur Heart J. 2006 Nov;27(22):2725-36. doi: 10.1093/eurheartj/ehl193. Epub 2006 Sep 25. Eur Heart J. 2006. PMID: 17000631 - Characteristics, outcomes, and predictors of 1-year mortality in patients hospitalized for acute heart failure.
Siirilä-Waris K, Lassus J, Melin J, Peuhkurinen K, Nieminen MS, Harjola VP; FINN-AKVA Study Group. Siirilä-Waris K, et al. Eur Heart J. 2006 Dec;27(24):3011-7. doi: 10.1093/eurheartj/ehl407. Epub 2006 Nov 24. Eur Heart J. 2006. PMID: 17127708 - The rationale and indications for angiotensin receptor blockers in heart failure.
Bybee KA, Das S, O'Keefe JH. Bybee KA, et al. Heart Fail Clin. 2006 Jan;2(1):81-8. doi: 10.1016/j.hfc.2005.11.003. Heart Fail Clin. 2006. PMID: 17386879 Review. No abstract available. - Sex differences in response to chronic heart failure therapies.
Ghali JK, Lindenfeld J. Ghali JK, et al. Expert Rev Cardiovasc Ther. 2008 Apr;6(4):555-65. doi: 10.1586/14779072.6.4.555. Expert Rev Cardiovasc Ther. 2008. PMID: 18402544 Review.
Cited by
- Real-World Clinical Burden of Newly Diagnosed Heart failure in Thai Patients.
Boonyapiphat T, Tangkittikasem T, Torpongpun A, Senthong V, Jiampo P. Boonyapiphat T, et al. Cardiol Ther. 2024 Jun;13(2):415-430. doi: 10.1007/s40119-024-00366-5. Epub 2024 May 6. Cardiol Ther. 2024. PMID: 38709436 Free PMC article. - Regional management of worsening heart failure: rationale and design of the CHAIN-HF registry.
Shakoor A, Emans ME, van Gent MWF, Hendrix A, Faber N, Springeling TS, de Vette LC, Manintveld OC, Denham RN, van de Meerendonk C, van der Boon RMA, Brugts JJ; Rijnmond Heart Failure Network. Shakoor A, et al. ESC Heart Fail. 2023 Jun;10(3):2074-2083. doi: 10.1002/ehf2.14354. Epub 2023 Mar 25. ESC Heart Fail. 2023. PMID: 36965147 Free PMC article. - Daily ambulatory remote monitoring system for drug escalation in chronic heart failure with reduced ejection fraction: pilot phase of DAVID-HF study.
Wong CK, Un KC, Zhou M, Cheng Y, Lau YM, Shea PC, Lui HW, Zuo ML, Yin LX, Chan EW, Wong ICK, Sin SWC, Yeung PPN, Chen H, Wibowo S, Wei TLN, Lee SM, Chow A, Tong RCF, Hai J, Tam FCC, Siu CW. Wong CK, et al. Eur Heart J Digit Health. 2022 May 7;3(2):284-295. doi: 10.1093/ehjdh/ztac024. eCollection 2022 Jun. Eur Heart J Digit Health. 2022. PMID: 36713022 Free PMC article. - Indirect comparison of SGLT2 inhibitors in patients with established heart failure: evidence based on Bayesian methods.
Chen HB, Yang YL, Meng RS, Liu XW. Chen HB, et al. ESC Heart Fail. 2023 Apr;10(2):1231-1241. doi: 10.1002/ehf2.14297. Epub 2023 Jan 26. ESC Heart Fail. 2023. PMID: 36702979 Free PMC article. - Outcomes and predictors of one-year mortality in patients hospitalized with Acute Heart Failure.
Lorlowhakarn K, Arayakarnkul S, Trongtorsak A, Leesutipornchai T, Kewcharoen J, Sinphurmsukskul S, Siwamogsatham S, Puwanant S, Ariyachaipanich A. Lorlowhakarn K, et al. Int J Cardiol Heart Vasc. 2022 Nov 30;43:101159. doi: 10.1016/j.ijcha.2022.101159. eCollection 2022 Dec. Int J Cardiol Heart Vasc. 2022. PMID: 36467463 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous